Trial · NCT01270256
NasoNeb Delivery of an Intranasal Steroid
NCT01270256, Phase 4, Completed, University of Chicago; results first posted 2014-07-16
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. NasoNeb Delivery of an Intranasal Steroid. Trials, record NCT01270256. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01270256
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- NasoNeb Delivery of an Intranasal Steroid
- NCT number
- NCT01270256
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 41 participants, actual
- Lead sponsor
- University of Chicago
- Conditions
- Perennial Allergic Rhinitis
- Interventions
- Budesonide, Placebo
- First posted
- 2011-01-05
- Last updated
- 2014-07-25
- Results first posted
- 2014-07-16
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Nasal Peak Inspiratory Flow (NPIF) | Baseline and 26 days | NPIF was measured objectively in liters per minute with an In-Check Peak \& Inspiratory Flow Meter (Ferraris Medical Inc, Orchard Park, NY). Subjects obtained 3 readings every morning and every evening and the greatest of the 3 measures were recorded. Total daily NPIF was calculated by adding the morning and evening values each day and the average of the change from baseline in NPIF for all days of was calculated |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Nasal Peak Inspiratory Flow (NPIF) | Baseline and 26 days | liters/min | MEDIAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Nasal Peak Inspiratory Flow (NPIF) | Budesonide | 36.41 | Standard Error 8.9 | liters/min | |
| Change in Nasal Peak Inspiratory Flow (NPIF) | Placebo | 18.71 | Standard Error 8.37 | liters/min |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Budesonide | 21 | |
| Overall Study | STARTED | Placebo | 20 | |
| Overall Study | COMPLETED | Budesonide | 20 | |
| Overall Study | COMPLETED | Placebo | 20 | |
| Overall Study | NOT COMPLETED | Budesonide | 1 | |
| Overall Study | NOT COMPLETED | Placebo | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Budesonide | ||
| Total, all-cause mortality | Placebo | ||
| Total, other adverse events | Budesonide | 0 | 20 |
| Total, other adverse events | Placebo | 0 | 20 |
| Total, serious adverse events | Budesonide | 0 | 20 |
| Total, serious adverse events | Placebo | 0 | 20 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 24574125 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Budesonide vs Placebo: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01270256
GET https://conductscience.org/api/trials/v1/NCT01270256/registered